Healthcare & Life Sciences
NexImmune
United Statesneximmune.com
NexImmune is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
Activeseries-b
series-b
Stage
2
Investors
About NexImmune
NexImmune is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
NexImmune develops antigen-directed immunotherapies using a proprietary AIM nanoparticle platform that programs T cell responses to treat cancer, autoimmune, and infectious diseases.
Explore NexImmune's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.